GDF15 and gastric cancer: A clinical study revealed that NAG-1 expression was upregulated in the serum of patients with gastric cancer and that its expression markedly correlated with cancer metastasis, suggesting an oncogenic role for NAG-1 during gastric cancer progression (25).